The company manufactures bio-based specialty chemicals, ethanol for fuel blending, and potable spirits using renewable feedstocks like molasses and grain. It serves industrial chemical users, oil marketing companies, and the consumer liquor market.
The company possesses a narrow moat derived from its scale and integrated manufacturing of bio-based chemicals, which are increasingly sought by global MNCs for ESG compliance. However, low ROCE and vulnerability to cheaper petrochemical-based alternatives from China suggest limited durable pricing power.
Management has focused on expanding distillery capacity and specialty chemical units to capture the ethanol blending mandate and premium liquor trends. Recent capital allocation includes a significant debt reduction using proceeds from a preferential equity issue to promoters.
The investment collapsed as the company's capital-intensive model failed to generate returns above its cost of capital, with ROCE stagnating near 10%. The anticipated ESG premium for bio-based chemicals evaporated as Chinese competitors flooded the market with cheaper petrochemical alternatives, stripping away the company's thin margins. Simultaneously, the heavy reliance on government-mandated ethanol blending prices turned into a trap when feedstock costs spiked, and the historical pattern of related-party transactions and preferential allotments to insiders signaled that minority shareholders were never the priority during the downturn.
RichFakir rates India Glycols Ltd's business quality as mediocre — 52/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, India Glycols Ltd is trading about 54% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on India Glycols Ltd is: Not rated. A mediocre business at a cheap price — it does not make our shortlist right now.
RichFakir's educational estimate of India Glycols Ltd's fair value is about ₹713 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →